Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
52 hedge funds and large institutions have $58M invested in Calithera Biosciences, Inc in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 11 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 5
118% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 11
33% more funds holding
Funds holding: 39 → 52 (+13)
60% less capital invested
Capital invested by funds: $143M → $58M (-$85.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $205K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.48M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$3.89M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.17M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.78M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.76M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
-$4.87M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$3.35M |
| 5 |
Jennison Associates
New York
|
-$2.71M |
CALA Hedge Fund Activity: Q2 2015 in Review
52 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2015, worth a combined $58M — down 60% from $143M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new CALA positions and 11 closed out — a net gain of 13 holders — while 20 added to existing stakes and 5 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $6.48M. The largest seller was T. Rowe Price Associates, cutting an estimated $14.2M.
- 52 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2015, up from 39 in Q1 2015.
- Funds reported $58M of Calithera Biosciences, Inc stock for Q2 2015, down 60% quarter-over-quarter.
- 24 funds opened new Calithera Biosciences, Inc positions in Q2 2015 and 11 closed out, a net change of +13 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2015 was Fidelity Investments, an estimated $6.48M added.
- The largest Calithera Biosciences, Inc seller in Q2 2015 was T. Rowe Price Associates, an estimated $14.2M sold.
Based on aggregated 13F filings for Q2 2015.